HH-006

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameHH-006
Drug Alias NameHH-006HH006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLarge envelope protein Pre-S1 inhibitors
TargetsLarge envelope protein Pre-S1
Therapy Area/IndicationsHepatitis DHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHuahui Health Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHuahui Health Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis DHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A